Back to top
more

Molina Healthcare (MOH)

(Real Time Quote from BATS)

$325.58 USD

325.58
79,638

-4.72 (-1.43%)

Updated Oct 10, 2024 02:56 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 5% (238 out of 250)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Tirthankar Chakraborty headshot

5 Stocks to Make the Most of the Halloween Effect

by Tirthankar Chakraborty

With a buying opportunity playing out in the stock market, investing in sound stocks like CalMaine Foods (CALM), Comstock Resources (CRK), Halliburton (HAL), PBF Energy (PBF) and Molina Healthcare (MOH) seems prudent.

Molina Healthcare (MOH) Q3 Earnings Top, 2022 EPS View Up

by Zacks Equity Research

Molina Healthcare's (MOH) third-quarter results reflect an expanding customer base within its Medicare and Medicaid businesses. Management hikes 2022 adjusted EPS guidance to a minimum of $17.75.

Molina (MOH) Q3 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Molina (MOH) delivered earnings and revenue surprises of 2.59% and 0.91%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Philips' (PHG) Q3 Earnings Down on Supply Chain Constraints

by Zacks Equity Research

Koninklijke Philips' (PHG) Q3 top and bottom-line results reflect the negative impact of supply chain constraints, COVID lockdowns in China and the Russia-Ukraine war.

Molina Healthcare (MOH) to Post Q3 Earnings: What to Expect

by Zacks Equity Research

Molina Healthcare's (MOH) Q3 results are expected to reflect better premiums and membership growth in its Medicaid and Medicare businesses, partly offset by steep general and administrative costs.

Should Value Investors Buy Molina Healthcare (MOH) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Elevance Health (ELV) Beats on Q3 Earnings, Ups '22 EPS View

by Zacks Equity Research

Elevance Health (ELV) is witnessing rapid growth in medical enrollment and expects to keep doing so.

Molina (MOH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Molina (MOH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Molina Healthcare, Inc (MOH) Hit a 52 Week High, Can the Run Continue?

by Zacks Equity Research

Molina (MOH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

UnitedHealth (UNH) Beats on Q3 Earnings, Ups 2022 EPS View

by Zacks Equity Research

UnitedHealth's (UNH) third-quarter results were supported by membership growth and strong Optum performance.

UnitedHealth Group (UNH) Surpasses Q3 Earnings and Revenue Estimates

by Zacks Equity Research

UnitedHealth (UNH) delivered earnings and revenue surprises of 6.24% and 0.21%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Derek Lewis headshot

These 3 Top-Ranked Low-Beta Stocks Are Great Shields Against Volatility

by Derek Lewis

With volatility headlining the market year-to-date, adding low-beta stocks to a portfolio can help soften large price swings.

Cigna (CI) to Offer Low-Cost Health Plans in 11 Texas Counties

by Zacks Equity Research

Cigna (CI) expects the 2023 Open Enrollment Period to start on Nov 1 for Texas residents.

Is Axonics (AXNX) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Axonics Modulation Technologies (AXNX) and Molina (MOH) have performed compared to their sector so far this year.

HCA Healthcare (HCA) Eyes 3 Hospital Divestments for $150M

by Zacks Equity Research

The divestment by HCA Healthcare (HCA) is likely to leave LCMC Health and Ochsner Health as the two major hospital care providers in the New Orleans region.

Why Molina (MOH) is a Top Value Stock for the Long-Term

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Are Investors Undervaluing Humana (HUM) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Ideas feature highlights: Molina Healthcare, McKesson and Humana

by Zacks Equity Research

Molina Healthcare, McKesson and Humana are part of the Zacks Investment Ideas article.

Derek Lewis headshot

3 Top-Ranked Healthcare Stocks Thriving in 2022

by Derek Lewis

Healthcare stocks generally carry a defensive nature, helping to shield investors from the market's volatility. Demand for the services these companies provide won't be going anywhere anytime soon.

UnitedHealth (UNH) Grows on Optum Strength, Cost Woes Stay

by Zacks Equity Research

UnitedHealth's (UNH) health service business, Optum, is becoming increasingly valuable and is crucial to the company's diversification strategy.

The Zacks Analyst Blog Highlights NextEra Energy, National Fuel Gas, General Mills, Constellation Brands and Molina Healthcare

by Zacks Equity Research

NextEra Energy, National Fuel Gas, General Mills, Constellation Brands and Molina Healthcare are part of The Zacks top Analyst Blog.

Nalak Das headshot

Defensive Sectors Likely to Shine for the Rest of 2022

by Nalak Das

We have selected five defensive stocks for the rest of 2022. These are: NEE, NFG, GIS, STZ and MOH.

Should Vanguard SmallCap Value ETF (VBR) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for VBR

Molina Healthcare (MOH) Wins Medicaid Deal From Nebraska DHHS

by Zacks Equity Research

Molina Healthcare (MOH) clinches a contract from the Nebraska DHHS, through which the health insurer can efficiently serve the state's Medicaid members and boost its statewide presence.

Centene's (CNC) Contract Win to Aid Nebraska's Medicaid Members

by Zacks Equity Research

The Nebraska DHHS awards a contract to Centene's (CNC) Nebraska arm to continue serving the unmet need of the state's Medicaid members with a suite of better healthcare options.